Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftazidime-tazobactam sodium (5:1) post-marketing safety and effectiveness study
CTR20140530Phase 4Active
- Sponsor
- Chongqing Kerui Pharmaceutical
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ceftazidime + tazobactam in There is no single canonical disease name for "acute bacterial infection" as it refers to a broad category of diseases rather than a specific condition., sponsored by Chongqing Kerui Pharmaceutical. Started Sep 2014; status: active.
02
Drugs
ceftazidime + tazobactam
03
Conditions
There is no single canonical disease name for "acute bacterial infection" as it refers to a broad category of diseases rather than a specific condition.
Beyond the preview
Go deeper on CTR20140530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140530.